Notas del episodio
Rheumatologist Joerg Ermann, MD, discusses biosimilars and how they are similar to biologics in the treatment of spondyloarthritis.
Palabras clave
biosimilarsafety
Rheumatologist Joerg Ermann, MD, discusses biosimilars and how they are similar to biologics in the treatment of spondyloarthritis.